Information Provided By:
Fly News Breaks for March 27, 2019
CCXI
Mar 27, 2019 | 04:54 EDT
B. Riley FBR analyst Harshita Polishetty upgraded ChemoCentryx to Buy from Neutral and raised her price target for the shares to $22 from $12.50.
News For CCXI From the Last 2 Days
There are no results for your query CCXI